Tristel Wipes system endorsed by scientific study in Singapore

East Anglian infection prevention products company Tristel has received a boost from a scientific report comparing the performance one of its key products against that of a major rival.

The study, conducted in the Ear, Nose and Throat (ENT) department at a hospital in Singapore in 2014 and just published a peer-reviewed journal, concluded that the Tristel Wipes system is comparable in its effectiveness for cleaning instruments to the leading disinfectant Rapicide while offering significant advantages to hospitals.

These include a rapid turnaround, of two to three minutes compared with 20 minutes for Rapicide, enabling clinics to see more patients, and grater portability, enabling instruments to be cleaned in emergency departments or on wards.

Paul Swinney, chief executive of Tristel, which is based near Newmarket, said: “We are pleased to see the publication in a peer-reviewed journal of yet another study comparing our wipe with a leading peracetic acid high-level disinfectant – Cantel’s Rapicide product.

“Peracetic acid is the most widely used high-level disinfectant chemistry in Europe and probably the United States also. The results affirm the key advantages of our wipes over alternative chemistries and disinfection methods.

“These advantages are the level and speed of kill and the capability of our wipes system to be deployed anywhere within a healthcare setting without the need for power, water and space. This is the 31st peer-reviewed and published scientific paper featuring Tristel products – a body of evidence of our products’ attributes that forms one of our company’s key strengths.”

The study was published in the International Journal of Otorhinolaryngology and Head and Neck Surgery.

Worldwide sales of the Tristel Wipes system totalled £11.5m in the financial year ending June 2017.